Image

Clinical Study of SMILE 4.0-VISULYZE in Correcting Refractive Errors

Clinical Study of SMILE 4.0-VISULYZE in Correcting Refractive Errors

Recruiting
18-40 years
All
Phase N/A

Powered by AI

Overview

The aim of this study is to further optimize the surgical input parameters for patients undergoing Small Incision Lenticule Extraction (SMILE) using the regression model established by the SMILE 4.0-VISULYZE system, thereby achieving satisfactory postoperative refractive outcomes.

In this study, patients scheduled for SMILE surgery at the investigators' hospital will be divided into two groups: a conventional group, where the input parameters are adjusted based on historical experience according to the patient's refractive error, and a 4.0-VISULYZE group, where the input parameters are optimized using the SMILE 4.0-VISULYZE system.

The investigators will compare the postoperative outcomes between the two groups, including uncorrected visual acuity (UCVA), best-corrected visual acuity (BCVA), spherical power, cylindrical power, spherical equivalent (SE), and the proportions of patients achieving postoperative visual acuity ≥0.8, ≥1.0, and ≥1.2 at 1 day, 10 days, 1 month, 3 months, 6 months, and 1 year post-surgery. Additionally, the investigators will evaluate the proportions of patients with postoperative SE within ±0.50D and ±1.0D, as well as postoperative cylindrical power within ±0.50D and ±1.0D, to assess the efficacy and safety of the SMILE 4.0-VISULYZE system in treating refractive errors.

Eligibility

Inclusion Criteria:

  1. The diopter is relatively stable (the diopter increases within -0.50D per year for 2 consecutive years);
  2. Age: 18 to 40 years old;
  3. Optimal preoperative corrected visual acuity ≥4.8;
  4. More than 2 weeks for soft contact lenses and more than 3 months for hard contact lenses before surgery
  5. Patients who are willing to perform SMILE surgery

Exclusion Criteria:

  1. Patients with history of eye surgery and trauma;
  2. Patients with keratoconus tendency;
  3. systemic connective tissue diseases and autoimmune diseases;
  4. Patients with high blood pressure, diabetes and heart disease history;
  5. Other eye disease history such as uveitis, scleritis and other eye inflammation patients;
  6. Patients with scar constitution.

Study details
    Refractive Surgery
    Myopia; Refractive Error

NCT06982807

Affiliated Hospital of Nantong University

31 May 2025

Step 1 Get in touch with the nearest study center
We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Investigator Avatar

Primary Contact

  Other languages supported:

First name*
Last name*
Email*
Phone number*
Other language

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.